Global Search | Novartis

Sort by

Relevance

Newest first

Oldest first

Hide Filters

Showing 3001 results

Clinical Trials / Oct 15, 2026

Dose-finding Study of YMI024 to Assess Efficacy, Safety, and Tolerability in Adults With Stable Coronary Artery Disease and Elevated hsCRP
Home
Careers
Story / Sep 23, 2026

The Day AI Made Me Rethink What Science Could Do

People and Culture

Christian Diehl, Chief Data & Digital Officer, Novartis Biomedical Research
Story / Sep 23, 2026

Fortune includes Novartis in 2026 Change The World List for malaria program

Access to Healthcare

For more than three decades, Novartis has been committed to the fight against malaria, one of the world's deadliest diseases. Fortune has now recognized that work by naming our malaria program to its 2026 Change The World list.
Clinical Trials / Sep 22, 2026

A Drug-drug Interaction Study to Assess the Effect of Phenytoin and Itraconazole on the Pharmacokinetics of Pelabresib in Healthy Participants
Clinical Trials / Sep 18, 2026

ASsessing The REAl-world Safety & Effectiveness of Spinal Muscular Atrophy Participants Treated With Intrathecal Onasemnogene Abeparvovec-brve (OAV101B) (ITVISMA®): A U.S. Pragmatic Multicenter Study (STREAM)
Clinical Trials / Oct 13, 2026

A Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Moderate to Severe Psoriatic Arthritis
Clinical Trials / Oct 15, 2026

Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Participants With Uncomplicated Plasmodium Falciparum Malaria (Cohort C2)
Clinical Trials / Oct 13, 2026

A Study to Evaluate Efficacy, Safety, and Tolerability of Remibrutinib in Adult Participants With Severe Chronic Pruritus of Unknown Origin (CPUO)